# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-20-015132
Filing Date
2020-06-17
Accepted
2020-06-16 19:13:08
Documents
15
Period of Report
2020-06-11
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea123112-8k_lanternpharma.htm | 8-K | 21177
2 | AMENDMENT TO CERTIFICATE OF INCORPORATION | ea123112ex3-1iv_lantern.htm | EX-3.1.IV | 1963
3 | AMENDED AND RESTATED CERTIFICATE OF INCORPORATION | ea123112ex3-1v_lantern.htm | EX-3.1.V | 4178
4 | PRESS RELEASE ANNOUNCING THE CLOSING OF THE INITIAL PUBLIC OFFERING | ea123112ex99-1_lantern.htm | EX-99.1 | 9151
5 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 14703
6 | GRAPHIC | ex3-1iv_001.jpg | GRAPHIC | 114827
7 | GRAPHIC | ex3-1iv_002.jpg | GRAPHIC | 313910
8 | GRAPHIC | ex3-1iv_003.jpg | GRAPHIC | 65150
9 | GRAPHIC | ex3-1v_001.jpg | GRAPHIC | 112144
10 | GRAPHIC | ex3-1v_002.jpg | GRAPHIC | 235217
11 | GRAPHIC | ex3-1v_003.jpg | GRAPHIC | 428398
12 | GRAPHIC | ex3-1v_004.jpg | GRAPHIC | 380207
13 | GRAPHIC | ex3-1v_005.jpg | GRAPHIC | 384080
14 | GRAPHIC | ex3-1v_006.jpg | GRAPHIC | 173925
15 | GRAPHIC | ex3-1v_007.jpg | GRAPHIC | 96316
| Complete submission text file | 0001213900-20-015132.txt |  | 3231595

Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

EIN.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 20967697
SIC: 2834 Pharmaceutical Preparations